Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

5-HT2 receptor ligands reported by Allelix

Aug. 16, 1996

Histamine H3 agonist increases slow-wave sleep in rats

Aug. 16, 1996

VML-251 phase IIa results reported

Aug. 16, 1996

Ono claims PGE2 agonists and antagonists

Aug. 16, 1996

Pain found to trigger unique pattern of brain responses

Aug. 16, 1996

Takeda seeks German approval for idebenone

Aug. 9, 1996

Neurex's SNX-111 progresses through clinical trials

Aug. 9, 1996

NMPA and/or AMPA antagonists from Warner-Lambert

Aug. 9, 1996

Sandoz's Exelon shows positive results in phase III

Aug. 9, 1996

NMDA antagonists claimed by E. Merck

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.